Signaling Pathways
Signaling Pathways(信号通路)
- Proteases(63)
- Apoptosis(1190)
- Chromatin/Epigenetics(17)
- Metabolism(420)
- MAPK Signaling(32)
- Tyrosine Kinase(97)
- DNA Damage/DNA Repair(62)
- PI3K/Akt/mTOR Signaling(56)
- Microbiology & Virology(68)
- Cell Cycle/Checkpoint(205)
- Ubiquitination/ Proteasome(43)
- JAK/STAT Signaling(13)
- TGF-β / Smad Signaling(30)
- Angiogenesis(85)
- GPCR/G protein(3)
- Stem Cell(27)
- Membrane Transporter/Ion Channel(273)
- Cancer Biology(514)
- Endocrinology and Hormones(168)
- Neuroscience(462)
- Obesity, Appetite Control & Diabetes(9)
- Peptide Inhibitors and Substrate(1)
- Other Signal Transduction(141)
- Immunology/Inflammation(1111)
- Cardiovascular(63)
- Vitamin D Related
- Antibody-drug Conjugate/ADC Related
- PROTAC(254)
- Ox Stress Reagents(25)
- Others(1718)
- Antiparasitics(21)
- Toxins(90)
Signaling Pathways 相关产品(35130)
- GC14518Asenapine hydrochlorideCAS: 1412458-61-7纯度: >99.50%
Asenapine hydrochloride 是一种抗精神病药,是一种 5-HT (1A, 1B, 2A, 2B, 2C, 5A, 6, 7) 和多巴胺 (D2, D3, D4) 受体拮抗剂,Ki 值为 0.03-4.0 nM,作用 5- HT 和多巴胺受体分别为 1.3、0.42、1.1 nM。
- GC14520(-)-p-Bromotetramisole OxalateCAS: 62284-79-1纯度: >99.50% / >98.00% / >99.00%
(-)-P-Bromotetramisole Oxalate是一种有效的非特异性碱性磷酸酶抑制剂。
- GC14538Pravastatin sodiumCAS: 81131-70-6纯度: >99.00% / >98.00%
Pravastatin sodium 是一种HMG-CoA可逆的竞争性抑制剂,IC 50 为5.6μM,通常用于高胆固醇血症和冠心病的研究。
- GC14548TPT-260 DihydrochlorideCAS: 2076-91-7纯度: >98.00%
A chaperone that stabilizes retromer complexes against thermal denaturation
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC14491 | B-HT 920 | 36085-73-1 | >99.50% | |
A potent agonist of D 2 receptors | ||||
| GC14507 | Azithromycin | 83905-01-5 | >98.00% | |
A macrolide antibiotic | ||||
| GC14509 | UPF 1069 | 1048371-03-4 | >99.00% / >98.00% | |
A selective PARP2 inhibitors | ||||
| GC14510 | PF-8380 | 1144035-53-9 | >99.00% | |
An inhibitor of autotaxin | ||||
| GC14512 | Fenspiride HCl | 5053-08-7 | >99.50% | |
A histamine H 1 receptor antagonist | ||||
| GC14517 | KPT-185 | 1333151-73-7 | - | |
An inhibitor of XPO1/CRM1 | ||||
| GC14518 | Asenapine hydrochloride | 1412458-61-7 | >99.50% | |
Asenapine hydrochloride 是一种抗精神病药,是一种 5-HT (1A, 1B, 2A, 2B, 2C, 5A, 6, 7) 和多巴胺 (D2, D3, D4) 受体拮抗剂,Ki 值为 0.03-4.0 nM,作用 5- HT 和多巴胺受体分别为 1.3、0.42、1.1 nM。 | ||||
| GC14520 | (-)-p-Bromotetramisole Oxalate | 62284-79-1 | >99.50% / >98.00% / >99.00% | |
(-)-P-Bromotetramisole Oxalate是一种有效的非特异性碱性磷酸酶抑制剂。 | ||||
| GC14522 | Acetarsone | 97-44-9 | - | |
An organoarsenic compound | ||||
| GC14523 | GM 6001 | 142880-36-2 | >98.00% | |
GM 6001 是一种广谱 MMP 抑制剂,可用于癌症和神经退行性疾病的研究,GM 6001对 MMP-1、2、3、8 和 9 的 Ki 值分别为 0.4、0.5、27、0.1和 0.2 nM。 | ||||
| GC14526 | CGK733 | 905973-89-9 | >99.50% | |
An anticancer compound | ||||
| GC14532 | TC-G 1006 | 1324003-64-6 | >99.50% | |
S1P1 Agonist III 是一种有效且具有口服活性的 S1P1 激动剂,EC50 为 18 nM; S1P3 上没有活动。 | ||||
| GC14534 | Regorafenib monohydrate | 1019206-88-2 | >99.50% | |
A multi-kinase inhibitor | ||||
| GC14536 | Metoprolol Tartrate | 56392-17-7 | - | |
An Analytical Reference Standard | ||||
| GC14538 | Pravastatin sodium | 81131-70-6 | >99.00% / >98.00% | |
Pravastatin sodium 是一种HMG-CoA可逆的竞争性抑制剂,IC 50 为5.6μM,通常用于高胆固醇血症和冠心病的研究。 | ||||
| GC14540 | SLIGKV-NH2 | 190383-13-2 | >98.00% | |
SLIGKV-NH2 (SLIGKV-NH2) 是一种高效的蛋白酶激活受体 2 (PAR2) 激活肽。 | ||||
| GC14548 | TPT-260 Dihydrochloride | 2076-91-7 | >98.00% | |
A chaperone that stabilizes retromer complexes against thermal denaturation | ||||
| GC14550 | SB271046 | 209481-20-9 | - | |
An orally-available 5-HT 6 antagonist | ||||
| GC14552 | LDK378 | 1032900-25-6 | >99.50% | |
An ALK inhibitor | ||||
| GC14553 | Resveratrol | 501-36-0 | >99.50% | |
白藜芦醇(转-白藜芦醇;SRT501)是一种植物抗菌素。 | ||||
| GC14562 | Nanaomycin A | 52934-83-5 | >98.00% | |
A bacterial metabolite | ||||
| GC14563 | Ketanserin | 74050-98-9 | >99.00% / >97.00% | |
A potent 5-HT 2 receptor antagonist | ||||
| GC14564 | Altretamine | 645-05-6 | >99.50% | |
An antineoplastic agent and GPX4 inhibitor | ||||
| GC14566 | CCT137690 | 1095382-05-0 | >99.00% | |
An inhibitor of Aurora kinases and FLT3 | ||||
